Sara Tirendi

4PUBLICATIONS
16CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 13, 2026
Amphiphilic Semisynthetic Triterpenoids Impair Survival Pathways and Suppress Clonogenic Growth in Multidrug-Resistant High-Risk Neuroblastoma.

|Jul 28, 2026
Heme Oxygenase-1 Contributes to Dampening Proinflammatory Activation in the Human Microglial Cell Line HMC3 and Controls the Transcription Factor IRF5.

|Apr 14, 2026
Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAFV600D,V600E PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting No/Low Toxicity on 3T3/HaCaT Cells.

Silvana Alfei, Maria Grazia Signorello, Sara Tirendi

|Jan 28, 2026
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells.

Carola Grondona, Barbara Marengo, Giulia Elda Valenti

Pageof 1

Frequent Collaborators

3 joint publications

Barbara Marengo

3 joint publications

Cinzia Domenicotti

2 joint publications

Silvana Alfei

2 joint publications

Elaheh Khaledizadeh